Large health systems look to the hub-and-spoke model for expanding MDx and other genomic technologies to smaller hospitals, according to HIMSS Analytics research.
Inscripta is creating its own market and customer base while also utilizing the expertise of its customers to refine and improve its products.
The firm said it will use the funding to expand its research capabilities, including the continued development of the MADzyme family of CRISPR enzymes.
The funding will help the Canadian cancer genomics firm expand distribution of its tumor tissue hotspot test, and development of its newer liquid biopsy assay.
WUSTL bioinformatics spinout PierianDx disclosed in an SEC filing that it has raised slightly more than $3 million of a $5 million offering.
VC firm Andreessen Horowitz is putting big money into its second biology-focused investment fund in hopes of supporting engineering approaches to science.
Microbiome Insights provides next-generation sequencing-based analytical testing and consulting services to microbiome researchers in academia and industry.
Commercialization efforts will focus on the most recent version of Genialis' platform, which includes tools for RNA-seq analysis and variant discovery.
The company will use the funds to expand its US-based business and to commercialize its data visualization platform.
The company will use the funds to increase its overseas footprint, and to optimize its genetic testing procedures and protocols, among other improvements.
Mice in New York harbor both antibiotic-resistant bacteria and novel viruses, according to a new analysis of their fecal microbiomes.
Human Heredity and Health in Africa Initiative has issued guidelines for genomic research in the region, according to Nature News.
The Associated Press reports that an ethicist predicts that prenatal diagnosis and other advances will lead to more choices being available to prospective parents.
In Genome Biology this week: approach to analyze alternative polyadenylation, algorithm to predict transcriptomic structural variations, and more.